NVO Stock: Novo Nordisk Pops as China Approves Wegovy Weight Loss Drug

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Novo Nordisk and Eli Lilly dominate the market for GLP-1 drugs, and are racing ahead to produce more of them.

The post NVO Stock: Novo Nordisk Pops as China Approves Wegovy Weight Loss Drug appeared first on InvestorPlace.

More From InvestorPlace

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• Legendary Investor Predicts: “Forget A.I. THIS Technology Is the Future”